Edition:
United Kingdom

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

11.57USD
20 Aug 2018
Change (% chg)

$0.03 (+0.22%)
Prev Close
$11.55
Open
$11.80
Day's High
$11.80
Day's Low
$11.45
Volume
171,757
Avg. Vol
224,689
52-wk High
$17.30
52-wk Low
$7.25

Chart for

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $846.68
Shares Outstanding(Mil.): 68.84
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.95 -- --
ROI: -129.83 1.78 14.61
ROE: -133.51 3.28 16.33

BRIEF-TG Therapeutics Reports Qtrly Loss Per Share Of $0.59

* TG THERAPEUTICS, INC. PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

Earnings vs. Estimates